US 10745466
Type III secretion system targeting molecules
granted A61KA61K38/00A61P
Quick answer
US patent 10745466 (Type III secretion system targeting molecules) held by Inhibrx, Inc. expires Mon Aug 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Inhibrx, Inc.
- Grant date
- Tue Aug 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 33
- CPC classes
- A61K, A61K38/00, A61P, A61P31/04